We’re working to help patients better manage chronic kidney disease (CKD) and end-stage renal disease (ESRD) by offering a simpler, more patient-centric approach, including an early intervention model.
Transforming kidney care
An estimated 37 million Americans live with chronic kidney disease (CKD) and nearly 700,000 have end stage renal disease (ESRD). Treatment can be challenging and costly for both patients and payers. In fact, dialysis alone costs Medicare approximately $120 billion annually. Yet, despite the enormous cost, patient outcomes are poor, with nearly one in six dialysis patients dying in the first year after starting treatment.
At CVS Health, we are working to fundamentally transform the treatment paradigm for the millions of patients with CKD and ESRD through CVS Kidney Care, a CVS Health company. Specifically, our CKD management program is focused on early identification of kidney disease, targeted patient engagement and ongoing education to help slow disease progression.
Earlier identification and better patient education
Many people who have kidney disease don’t know it. In fact, in the U.S., 43 percent of those with severely reduced kidney function are not aware that they have chronic kidney disease. By promoting early diagnosis, we will work to help delay the onset of dialysis and avoid emergency hospitalization, which is one of the biggest drivers of cost in kidney care.
Our CKD care management program is focused on helping people understand their condition, delay the need for dialysis, and make confident treatment decisions when the time comes. For more information, visit the CVS Kidney Care website.
Aligned with HHS priorities
In 2019, an executive order aimed at improving kidney care helped launch a new Advancing Kidney Health initiative of the Department of Health and Human Services (HHS). This marked an important step forward in kidney care as the administration pledged to double the number of kidney transplants performed in the U.S and reduce ESRD kidney failure by 25 percent by 2030 through better education and care during early forms of the disease. Furthermore, the administration wants 80 percent of newly diagnosed people with kidney failure to receive a transplant or move from clinic-based dialysis to less expensive and more effective in-home care by 2025.
Our CVS Kidney Care focus aligns with the core objectives of this new initiative, and uniquely positions us to help advance and support the administration’s directives to improve early detection of and expand treatment options for kidney care. Across our CVS Health enterprise, we are committed to transforming the health care system to better meet the needs of patients and reduce overall costs. Our unique approach to kidney care is one way that we are doing this as we work to help more people on their path to better health.
Visit the CVS Kidney Care website to learn more about our offerings.